Microcarrier Market (By Product Type: Equipment, Consumables; By Application: Vaccine Manufacturing; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

The global microcarrier market was surpassed at USD 1.93 billion in 2021 and is expected to hit around USD 5.10 billion by 2030, growing at a CAGR of 11.4% from 2022 to 2030.

Microcarrier Market Size 2021 to 2030

Microcarrier is a small bead-like material used to immobilize biocatalysts or to adhere to the growing cells to be cultivated in bioreactors. It acts like a support matrix. The cells grow on the microcarriers which are spherical and called beads. It provides the approach for the expansion of the cell culture system which is beneficial for gene and cell-based therapies and research activities. Microcarrier has wide application in vaccine production using packaging cell lines. The most commonly used cell types are Vero cells. Microarray technology also has advantages in the pharmaceutical and biotech sector, as follows –

  • Easy scale-up process
  • Ability to control the conditions of cell growth for the advanced bioreactors which are computer-controlled
  • Reduced technical labor
  • Providing natural environment for the cell culture

Scope of The Report

Report Coverage Details
Market Size in 2021 USD 1.93 billion
Revenue Forecast by 2030 USD 5.10 billion
Growth rate from 2022 to 2030 CAGR of 11.4%
Base Year 2021
Forecast Period 2022 to 2030
Segmentation Product Type, Application, End-user, Region
Companies Covered

Sartorius AG, GE Healthcare, Thermo Fisher Scientific Inc., Corning Incorporated, Merck KGaA, Danaher Corporation, Lonza, Eppendorf AG, Becton, Dickinson and Company, HiMedia Laboratories, others

 

Vaccine production and cell therapy are the major driving factors for enhancing the growth of microcarrier markets. Vaccines produced from microcarriers or cell cultures is the most efficient method as the process has a short lead time and large production quantity. Clinical trials have also proved that this is a safe and effective process. Moreover, the funding from the private as well as public sector companies is increasing for cell-based vaccine production. The commercially available microcarriers in the market are alginate-based, dextran-based, collagen-based, and polystyrene-based. Some examples of such microcarriers are GEM, Cytodex, GE Healthcare, Cultispher, Percell, and SoloHill Engineering. On the other hand, the downstream process cost of the microcarrier culture is high. This can be one of the restraints for the microcarrier markets for small-scale companies with low budgets. Recently, Sartorius Stedim Biotech (SSB) launched a mini bioreactor vessel for the production of vaccines using microcarrier cell culture. The rise in cancer cases which is observed globally is boosting the growth of markets.

The market is segmented based on product type, application, end-user, and region. The market is segmented based on the product type into equipment, consumables, and microcarrier beads. Based on the application segment it is further segmented into gene therapy, vaccine manufacturing, biologics manufacturing, tissue engineering, and regenerative medicines among others. End users like pharmaceutical and biotechnology industries, CROs, and Research Institutes hold the major markets as they contribute to the invention, discovery, and improvement of human lives.

Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. As per the research, North America holds the major market due to the higher prevalence of chronic diseases. Also, North America has a well-developed healthcare infrastructure and growing healthcare sector which contributes to the market growth. This is due to the increasing investments and funding by private and public companies along with research institutes. The European market is also projected to expand due to increasing investment by companies in the region. Recently, Sartorius, Germany has obtained the SoloHill portfolio of Danaher Corporation, thus expanding its microcarrier portfolio. The company has also introduced a mini microcarrier bioreactor vessel. ABL Europe and Sartorius have signed an agreement for implementing the manufacturing facility in Strasbourg.

Key Players

  • Sartorius AG
  • GE Healthcare
  • Thermo Fisher Scientific Inc.
  • Corning Incorporated
  • Merck KGaA
  • Danaher Corporation
  • Lonza
  • Eppendorf AG
  • Becton
  • Dickinson and Company
  • HiMedia Laboratories
  • others

Market Segmentation

  • By Product Type
    •  Equipment
    • Consumables
      • Media
      • Reagents
    • Microcarrier Beads
  • By Application
    • Vaccine Manufacturing
    • Cell and Gene Therapy 
    • Biologics
    • Manufacturing
    • Tissue Engineering
    • Others
  • By End-user
    • Academic and Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • Contract Research Organizations
  • By Region
    • North America
    • Europe 
    • Asia-Pacific
    • Latin America
    • Middle East And Africa

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Microcarrier Market 

5.1. COVID-19 Landscape: Microcarrier Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Microcarrier Market, By Product

8.1. Microcarrier Market, by Product, 2022-2030

8.1.1 Equipment

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Consumables

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Microcarrier Beads

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Microcarrier Market, By Application

9.1. Microcarrier Market, by Application, 2022-2030

9.1.1. Vaccine Manufacturing

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Cell and Gene Therapy

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Biologics

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Manufacturing

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Tissue Engineering

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Microcarrier Market, By End-user 

10.1. Microcarrier Market, by End-user, 2022-2030

10.1.1. Academic and Research Institutes

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Pharmaceutical and Biotechnology Companies

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Contract Research Organizations

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Microcarrier Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.3. Market Revenue and Forecast, by End-user (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.4.3. Market Revenue and Forecast, by End-user (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.5.3. Market Revenue and Forecast, by End-user (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.3. Market Revenue and Forecast, by End-user (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.4.3. Market Revenue and Forecast, by End-user (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.5.3. Market Revenue and Forecast, by End-user (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.6.3. Market Revenue and Forecast, by End-user (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.7.3. Market Revenue and Forecast, by End-user (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.3. Market Revenue and Forecast, by End-user (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.4.3. Market Revenue and Forecast, by End-user (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.5.3. Market Revenue and Forecast, by End-user (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.6.3. Market Revenue and Forecast, by End-user (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.7.3. Market Revenue and Forecast, by End-user (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.3. Market Revenue and Forecast, by End-user (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.4.3. Market Revenue and Forecast, by End-user (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.5.3. Market Revenue and Forecast, by End-user (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.6.3. Market Revenue and Forecast, by End-user (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.7.3. Market Revenue and Forecast, by End-user (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.3. Market Revenue and Forecast, by End-user (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.4.3. Market Revenue and Forecast, by End-user (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.5.3. Market Revenue and Forecast, by End-user (2017-2030)

Chapter 12. Company Profiles

12.1. Sartorius AG

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. GE Healthcare

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Thermo Fisher Scientific Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Corning Incorporated

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Merck KGaA

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Danaher Corporation

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Lonza

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Eppendorf AG

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Becton

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Dickinson and Company

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers